At the MAPS 2022 Global Annual Meeting, we sat down with Riad Dirani and Omar Dabbous to chat about the structure and activities of HEOR within Medical Affairs.
In this interview recorded at MAPS 2022 Global with Lobna Salem we discuss building a Medical Affairs department from the ground up.
MAPS speaks with José Borbolla, Global Executive Medical Director at Esai, and Augusto Grinspan, VP Medical Affairs and Head LATAM with Merck KGaA about the evolution of Medical Affairs in Latin America.
In this interview recorded at MAPS 2022 Global with Marija Geertsen, MD, MBA, we discuss the role of Medical Affairs in engaging with patients and patient communities.
In this interview recorded at MAPS 2022 Global with Monica de Abadal, SVP, Head North America Medical Affairs, Ipsen, we discuss how Medical Affairs benefits patients and society.
This podcast, recorded at the MAPS 2022 Global Annual Meeting, addresses the unique position of Medical Affairs in the rare disease space & how our work in this area is essential for patient benefit.
Charlotte Kremer (former Astellas) speaks with Danie du Plessis (Kyowa Kirin) and Bjorn Oddens (Merck) about whether Medical Affairs is truly the third strategic pillar.
How do leaders make their way to Medical Safety & Pharmacovigilance? The routes are diverse but one constant remains true: They are extremely committed to being an independent voice that amplifies their organization’s commitment to Patient Centricity.
In this final article in the Leadership Perspectives series, John Pracyk interviews J&J leaders to explore a bold vision of career development that entails moving across sectors; namely, crossing over between Pharmaceuticals, Medical Devices, Vision, and Consumer Health.
In conversation with John Pracyk, MD, PhD, MBA, Medical Affairs leaders from Johnson & Johnson describe best practices to prepare our next generation of Chief Medical Officers.